Antioxidant supplementation and risk of chronic disease.
Aro
Antti
A
National Public Health Institute, Helsinki, Finland. antti.aro@ktl.fi
D000975:Antioxidants / Q000008:administration & dosage* / Q000627:therapeutic use; D002908:Chronic Disease / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D003327:Coronary Disease / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D019587:Dietary Supplements; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D012307:Risk Factors; D012643:Selenium / Q000008:administration & dosage / Q000627:therapeutic use; D024502:alpha-Tocopherol / Q000008:administration & dosage / Q000627:therapeutic use; D019207:beta Carotene / Q000008:administration & dosage / Q000627:therapeutic use
D000975:Antioxidants; D019207:beta Carotene; D024502:alpha-Tocopherol; D012643:Selenium